SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. (2021)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)01358-1
PubMed Identifier: 34139198
Publication URI: http://europepmc.org/abstract/MED/34139198
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10293
ISSN: 0140-6736